DISE: Phenotyping Obstruction Patterns
Launched by UNIVERSITY OF PENNSYLVANIA · Sep 9, 2021
Trial Information
Current as of August 19, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial, called DISE: Phenotyping Obstruction Patterns, is studying a procedure called drug-induced sleep endoscopy (DISE) to better understand how the upper airway behaves during sleep in patients with obstructive sleep apnea (OSA). The researchers want to see how different factors, like the structure of the airway and muscle function, affect airflow and breathing. By using a device that applies gentle air pressure (like a CPAP machine) during the DISE procedure, along with imaging techniques like CT scans and ultrasounds, they aim to find out what causes blockages in the airway during sleep. This information could help develop personalized treatment options for patients who struggle with sleep-related breathing issues.
To participate in this trial, adults aged 18 and older who are scheduled for a DISE procedure and are looking for alternatives to CPAP therapy may be eligible. There are no specific exclusions, so if you are interested and meet the age requirement, you can consider joining. Participants can expect to undergo the DISE procedure with additional tests that will help the researchers gather detailed information about their airway. This study aims to improve how doctors assess and treat sleep apnea, ultimately leading to better outcomes for patients.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • 1. Adults (≥ 18yrs) willing and capable of providing informed consent.
- • 2. English-speaking \& able to give Informed Consent.
- • 3. Referred or scheduled for clinically indicated DISE procedure.
- • 4. Seeking CPAP alternatives for treatment of sleep disordered breathing.
- Exclusion Criteria:
- • None
About University Of Pennsylvania
The University of Pennsylvania, a prestigious Ivy League institution located in Philadelphia, is renowned for its commitment to advancing medical research and improving healthcare outcomes. As a clinical trial sponsor, the university leverages its extensive resources, interdisciplinary expertise, and cutting-edge facilities to conduct innovative studies across various therapeutic areas. With a focus on translating scientific discoveries into clinical applications, the University of Pennsylvania fosters collaborations among leading researchers, clinicians, and industry partners, ensuring rigorous trial design and adherence to ethical standards. Through its dedication to excellence in research and education, the university plays a pivotal role in shaping the future of medicine.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Philadelphia, Pennsylvania, United States
Patients applied
Trial Officials
Raj C Dedhia, MD, MSCR
Principal Investigator
University of Pennsylvania
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials